← FDA Drug Approvals (Drugs@FDA)
ANKTIVA
BLA · Biologics License Application · Sponsor: ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU · Approved 2024-04-22
Drug application
- FDA Application #
BLA761336- Application type
- Biologics License Application
- Brand name
- ANKTIVA
- Generic name
- NOGAPENDEKIN ALFA INBAKICEPT-PMLN
- Active ingredients
- nogapendekin alfa inbakicept-pmln
- Dosage form
- SOLUTION
- Route
- INTRAVESICAL
- Marketing status
- Prescription
- Sponsor
- ALTOR BIOSCIENCE, LLC, AN INDIRECT WHOLLY-OWNED SU
- Manufacturer
- Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc.
- First approval
- 2024-04-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown